ValuEngine upgraded shares of Xylem (NYSE:XYL) from a hold rating to a buy rating in a report released on Tuesday.
Other research analysts also recently issued reports about the company. Cowen reaffirmed a buy rating and issued a $85.00 price target on shares of Xylem in a research report on Friday, October 12th. Oppenheimer reaffirmed a buy rating on shares of Xylem in a research report on Tuesday, July 31st. Royal Bank of Canada reissued a buy rating and set a $77.00 price objective on shares of Xylem in a report on Wednesday, October 31st. Seaport Global Securities set a $80.00 price objective on Xylem and gave the stock a buy rating in a report on Wednesday, October 31st. Finally, Robert W. Baird reissued a hold rating and set a $80.00 price objective on shares of Xylem in a report on Wednesday, August 1st. One analyst has rated the stock with a sell rating, five have issued a hold rating and nine have issued a buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus target price of $79.57.
Shares of XYL stock opened at $69.85 on Tuesday. The company has a current ratio of 1.49, a quick ratio of 1.07 and a debt-to-equity ratio of 0.83. Xylem has a twelve month low of $63.71 and a twelve month high of $82.44. The company has a market capitalization of $12.22 billion, a P/E ratio of 29.10, a P/E/G ratio of 1.31 and a beta of 1.24.
The business also recently declared a quarterly dividend, which will be paid on Friday, December 7th. Investors of record on Thursday, November 1st will be paid a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 1.20%. The ex-dividend date of this dividend is Wednesday, October 31st. Xylem’s dividend payout ratio is 35.00%.
In related news, insider Paul A. Stellato sold 3,000 shares of the business’s stock in a transaction on Monday, September 10th. The stock was sold at an average price of $78.63, for a total value of $235,890.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Colin R. Sabol sold 17,161 shares of the business’s stock in a transaction on Monday, September 17th. The shares were sold at an average price of $81.37, for a total value of $1,396,390.57. Following the completion of the sale, the insider now directly owns 41,988 shares in the company, valued at approximately $3,416,563.56. The disclosure for this sale can be found here. In the last ninety days, insiders sold 21,661 shares of company stock worth $1,755,281. 0.81% of the stock is owned by insiders.
A number of hedge funds have recently made changes to their positions in XYL. Flagship Harbor Advisors LLC acquired a new stake in Xylem in the 2nd quarter valued at $106,000. Smithfield Trust Co. boosted its stake in Xylem by 1,690.0% in the second quarter. Smithfield Trust Co. now owns 1,611 shares of the industrial products company’s stock worth $108,000 after purchasing an additional 1,521 shares in the last quarter. Fort L.P. acquired a new position in Xylem in the second quarter worth $118,000. Stelac Advisory Services LLC acquired a new position in Xylem in the second quarter worth $125,000. Finally, Pendal Group Ltd acquired a new position in Xylem in the third quarter worth $126,000. 84.40% of the stock is currently owned by institutional investors and hedge funds.
Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.
See Also: Inflation
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.